Evidence map›Paper›PMID 33417688›Full record

ArticleThe Journal of infectious diseases2021

Cytokine Augmentation Reverses Transplant Recipient Neutrophil Dysfunction Against the Human Fungal Pathogen Candida albicans.

Nicolas Barros, Natalie Alexander, Adam Viens, Kyle Timmer, Natalie Atallah, Sally A I Knooihuizen, Alex Hopke, Allison Scherer, Zeina Dagher, Daniel Irimia and 1 more

Open access · greenAbstract read
In one paragraph

Article in The Journal of infectious diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. TLR Signaling Rescues Fungicidal Activity in Syk-Deficient Neutrophils.Journal of immunology (Baltimore, Md. : 1950) · 2022
    Article
  13. Suppression ofFrontiers in microbiology · 2022
    Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Nicolas BarrosDivision of Infectious Diseases, Indiana University Health, Indianapolis, Indiana, USA.
Natalie AlexanderDivision of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, USA.
Adam ViensDivision of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, USA.
Kyle TimmerDivision of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, USA.
Natalie AtallahDivision of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, USA.
Sally A I KnooihuizenDepartment of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
Alex HopkeHarvard Medical School, Boston, Massachusetts, USA.
Allison SchererDivision of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, USA.
Zeina DagherDivision of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, USA.
Daniel IrimiaHarvard Medical School, Boston, Massachusetts, USA.
Michael K MansourDivision of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, USA.
Massachusetts General Hospital · USHarvard University · USIndiana University – Purdue University Indianapolis · US

Funding

Neutrophil Decision Making in Confined Environments in Health and DiseaseR01GM092804 · NIGMS · MASSACHUSETTS GENERAL HOSPITAL · PI IRIMIA, DANIEL · 2010 to 2022
$4.3M
The role of spleen tyrosine kinase (syk) in neutrophil responses to pathogenic fungi.R01AI132638 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI MANSOUR, MICHAEL K · 2018 to 2021
$1.6M
NIAID NIH HHS R01 AI132638NIGMS NIH HHS R01 GM092804
6 · The paper itself

Abstract

backgroundSolid organ transplant (SOT) and stem cell transplant (SCT) recipients are at increased risk of invasive fungal disease despite normal neutrophil counts. Here, we measure neutrophil anti-Candida activity.

methodsTwenty-one SOT and 19 SCT recipients were enrolled 2-4 months posttransplant and compared to 23 healthy control patients (HC). Neutrophils were coincubated with Candida albicans, and percentage killing and swarming responses were measured.

resultsNeutrophils from transplant patients had decreased fungicidal capacity compared to HC (42%, 43%, and 72% for SCT, SOT, and HC, respectively; SCT vs HC: P < .0001; SOT vs HC: P < .0001; SOT vs SCT: P = .8), including diminished ability to control hyphal growth (HC vs SOT: 0.1455 vs 0.3894, P ≤ .001; HC vs SCT: 0.1455 vs 0.6295, P ≤ .0001, respectively). Serum from SCT, but not SOT, recipients, inhibited the ability of HC neutrophils to control C. albicans (37%, 45%, and 55% for SCT, SOT, and HC, respectively). Neutrophils' control of hyphal growth was partially restored with granulocyte colony-stimulating factor or granulocyte macrophage colony-stimulating factor.

conclusionsDespite normal circulating numbers, our data suggest that neutrophils from SOT and SCT recipients mount dysfunctional responses against C. albicans. Intrinsic neutrophil changes and extrinsic serum factors may be responsible for the dysfunction, which is partially reversed with cytokine augmentation.

Indexed as

CytokinesNeutrophilsTransplant RecipientsAntifungal AgentsCandidaCandida albicansHumansOrgan TransplantationStem Cell TransplantationTransplantsAntifungal AgentsCytokinesCandidahost–pathogen interactioninnate immunityneutrophilsolid organ transplantstem cell transplanttransplant

Identifiers

PMID33417688
PMCPMC8577195
OpenAlexW3119935891

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.